- Home
- MPW vs SLP Comparison
MPW vs SLP Comparison
Compare MPW & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPW
- SLP
- Stock Information
- Founded
- MPW 2003
- SLP 1996
- Country
- MPW United States
- SLP United States
- Employees
- MPW N/A
- SLP N/A
- Industry
- MPW Real Estate Investment Trusts
- SLP EDP Services
- Sector
- MPW Real Estate
- SLP Technology
- Exchange
- MPW Nasdaq
- SLP Nasdaq
- Market Cap
- MPW 3.3B
- SLP 708.1M
- IPO Year
- MPW 2005
- SLP 1997
- Fundamental
- Price
- MPW $5.24
- SLP $30.02
- Analyst Decision
- MPW Hold
- SLP Buy
- Analyst Count
- MPW 6
- SLP 8
- Target Price
- MPW $5.75
- SLP $47.83
- AVG Volume (30 Days)
- MPW 8.8M
- SLP 448.0K
- Earning Date
- MPW 05-01-2025
- SLP 07-01-2025
- Dividend Yield
- MPW 6.09%
- SLP 0.20%
- EPS Growth
- MPW N/A
- SLP N/A
- EPS
- MPW N/A
- SLP 0.36
- Revenue
- MPW $994,615,000.00
- SLP $78,564,000.00
- Revenue This Year
- MPW N/A
- SLP $30.38
- Revenue Next Year
- MPW $5.07
- SLP $11.97
- P/E Ratio
- MPW N/A
- SLP $83.86
- Revenue Growth
- MPW 23.51
- SLP 21.49
- 52 Week Low
- MPW $3.51
- SLP $23.01
- 52 Week High
- MPW $6.55
- SLP $51.22
- Technical
- Relative Strength Index (RSI)
- MPW 46.18
- SLP 45.26
- Support Level
- MPW $5.00
- SLP $27.85
- Resistance Level
- MPW $5.85
- SLP $36.45
- Average True Range (ATR)
- MPW 0.20
- SLP 1.59
- MACD
- MPW -0.01
- SLP -0.75
- Stochastic Oscillator
- MPW 28.24
- SLP 25.23
About MPW Medical Properties Trust Inc. common stock
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. The group's geographic areas are the United States, the United Kingdom, and All other countries.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.